课题基金 / 基金详情

A rapid realist review of community pharmacy support for the public health agenda during the COVID-19 pandemic and future health emergencies

A rapid realist review of community pharmacy support for the public health agenda during the COVID-19 pandemic and future health emergencies
对 COVID-19 大流行和未来突发卫生事件期间社区药房对公共卫生议程的支持进行快速现实审查
批准号:
MR/V021206/1
负责人:
Ian Derek Maidment
金额:
$10.98万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2020
资助国家:
英国
项目状态:
已结题
起止时间:
2020 至 --

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
背景:社区药房在抗击新冠肺炎的战斗中发挥着关键作用,例如接种疫苗、分发药品和提供建议。这个项目使用了一种叫做“现实主义审查”的方法。这是理解复杂情况并了解社区药房如何应对新冠肺炎带来的挑战的理想选择。由此,将产生指导意见。计划方法:我们将通过研究学术论文和其他文献,从已经写的东西中吸取教训。我们将致力于找到有关社区药房如何应对新冠肺炎当前挑战的文档。由此,我们将得出‘什么对谁起作用,什么时候起作用,如何起作用,为什么起作用?’并制定指导意见。我们将与患者和护理人员讨论我们从文献中学到的知识,包括药房、疗养院工作人员和全科医生及其同事(“关键利益相关者”)。这些利益相关者将建议我们的发现是否有意义,并帮助我们制定在“现实世界”有效的指导。传播(分享我们的发现):我们将与患者、政策制定者、社区药房和全科医生分享我们的发现和建议。我们将与主要专业团体合作,迅速分享我们的指导方针。
英文摘要
Background: Community pharmacy has a key role in the battle against COVID-19, for example vaccination, dispensing medicines and giving advice. This project uses an approach called "realist review". This is ideal to make sense of complex situations and understand how community pharmacy can support the challenges presented by COVID-19. From this, guidance will be produced. Planned Methods: We will learn lessons from what has already been written by studying academic papers and other documents. We will aim to find documents with information on how community pharmacy can support the current challenges of COVID-19. From this we will work out 'what works for whom, when, how and why?' and develop guidance. Our learning from the literature will be discussed with patients and care staff including pharmacy, care home staff, and GPs and their colleagues ("key stakeholders"). These stakeholders will advise us whether our findings make sense and help us to develop guidance that works in the "real world". Dissemination (sharing our findings): We will share our findings and suggestions with patients, policy-makers, community pharmacy and GPs. We will work with key professional bodies to rapidly share our guidelines.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
海外基金